跳至主要内容
临床试验/IRCT20220404054402N1
IRCT20220404054402N1招募中2 期

Evaluation of the effectiveness of with different types of anticoagulants treatment in patients with atrial fibrillation in one-year follow-up in preventing stroke and bleeding complications comparison of drugs warfarin rivaroxaban and apixaban

Ahvaz University of Medical Sciences0 个研究点目标入组 198 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
198

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age > 18 years
  • Diagnosis of atrial fibrillation
  • Informed consent to participate in the study
  • Elevated CHA2DS2-VASc score of 2 or greater in men or 3 or greater in women

排除标准

  • Patients treated with multiple oral anticoagulants
  • Taking multiple doses of the drug
  • Taking drugs with indications other than prevention of stroke and hemorrhage
  • Loss to follow-up before 1 year
  • Patients without comorbidity known to be associated with higher mortality such as heart failure, cancer, chronic pulmonary disease

研究者

相似试验